<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04114708</url>
  </required_header>
  <id_info>
    <org_study_id>19-01185</org_study_id>
    <nct_id>NCT04114708</nct_id>
  </id_info>
  <brief_title>MRI Review of ACLR With and Without Lateral Extra-articular Tenodesis</brief_title>
  <official_title>MRI Review of ACLR With and Without Lateral Extra-articular Tenodesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the proposed study is to evaluate the effect of lateral extra-articular&#xD;
      tenodesis (LET) on anterior cruciate ligament reconstruction through evaluation of&#xD;
      postoperative magnetic resonance imaging (MRI). This will be a single-center non-randomized&#xD;
      controlled study. The study is comparing postoperative graft MRI findings in two cohorts:&#xD;
      patients undergoing isolated ACLR and patients undergoing ACLR with lateral extra-articular&#xD;
      tenodesis (LET). Postoperative MRIs will be obtained at 6, 9 and 12 months postoperatively.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine if ACLR supplementation with LET results in superior MRI findings relative to ACLR alone</measure>
    <time_frame>1 Year</time_frame>
    <description>MRI findings will be compared in patients receiving ACLR+LET versus just ACLR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Graft Failure</measure>
    <time_frame>1 Year</time_frame>
    <description>Defined as either symptomatic instability requiring revision or symptomatic instability with positive pivot shift or asymmetrical pivot shift greater than the contralateral side.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Ruptured Achilles Tendon</condition>
  <arm_group>
    <arm_group_label>ACLR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients will undergo an anatomic ACLR via a standardized fashion using BTB autogaft graft.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACLR with lateral extra-articular tenodesis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All LETs will be performed in a standardized fashion using the modified Lameire technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Anterior cruciate ligament Reconstruction (ACLR)</intervention_name>
    <description>All patients will undergo an anatomic ACLR via a standardized fashion using BTB autograft.</description>
    <arm_group_label>ACLR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ACLR with lateral extra-articular tenodesis (LET)</intervention_name>
    <description>All LETs will be performed in a standardized fashion using the modified Lameire technique. All patients will undergo an anatomic ACLR via a standardized fashion using BTB autogaft graft.</description>
    <arm_group_label>ACLR with lateral extra-articular tenodesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ACL deficient knee&#xD;
&#xD;
          -  skeletally mature (as defined by closed growth plates on plain radiograph)&#xD;
&#xD;
          -  at least 13 years of age&#xD;
&#xD;
          -  less than 26 years of age&#xD;
&#xD;
          -  not pregnant&#xD;
&#xD;
          -  two or more of following criteria: competitive pivoting sport, grade 2 pivot shift or&#xD;
             - greater, generalized ligament laxity (beighton score of 4 or greater )&#xD;
&#xD;
          -  no concomitant lateral meniscus tear&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  knee with intact ACL&#xD;
&#xD;
          -  skeletally immature (as defined by open physis on plain radiograph)&#xD;
&#xD;
          -  less than two of following criteria: competitive pivoting sport, grade 2 pivot shift&#xD;
             or - greater, generalized ligament laxity (beighton score of 4 or greater )&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  less than 13 years of age&#xD;
&#xD;
          -  older than age 25&#xD;
&#xD;
          -  previous ACL repair&#xD;
&#xD;
          -  concomitant lateral meniscus tear&#xD;
&#xD;
          -  unable to speak english or perform informed consent&#xD;
&#xD;
          -  multiligamentous knee injury (two or more ligaments requiring surgical attention)&#xD;
&#xD;
          -  varus or valgus malalignment greater than 3 degrees&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laith Jazrawi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dhruv Shankar</last_name>
    <phone>240-506-1000</phone>
    <email>dhruv.shankar@nyulangone.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Dhruv Shankar</last_name>
      <phone>240-506-1000</phone>
      <email>dhruv.shankar@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Laith Jazrawi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 24, 2019</study_first_submitted>
  <study_first_submitted_qc>October 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2019</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.</ipd_time_frame>
    <ipd_access_criteria>Requests should be directed to david.bloom@nyulangone.org To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

